[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"tumor-cells-circulating\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:tumor-cells-circulating":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":14,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100567750",false,"NCT06672250","The Correlation Between Circulatory Tumor Cells and Venous Thrombosis","Inclusion Criteria:\n\n1. age≧18\n2. participants (1)participants without cancer: without cancer in five years (2)participants with cancer:pathology reveal have malignant tumor\n3. patients who underwent catheter-based thrombectomy\n4. agree do the thrombectomy\n\nExclusion Criteria:\n\n1. participants without cancer (1).shock (2).severe sepsis (3).with cancer in five years\n2. participants with cancer (1).shock (2).severe sepsis",true,"ALL","18 Years","80 Years",{"count":19,"type":20},120,"ESTIMATED","1 Day","OBSERVATIONAL","Research indicates a strong correlation between cancer and thrombosis, with approximately 20% of blood clots in the U.S. being cancer-related, according to CDC data. Cancer patients face a 4-7 times higher risk of thrombosis compared to non-cancer individuals. Certain cancer treatments, such as chemotherapy and targeted therapy, elevate the likelihood of venous thromboembolism (VTE). Cancer patients with VTE exhibit a significantly higher hazard ratio (H.R.) of 3.4 compared to those without VTE.\n\nThis study aims to explore three main topics: (1) Comparing the differences and similarities of leukocyte populations between cancer-associated thrombosis (CAT) and venous thromboembolism (VTE). (2) Characterizing the factors contributing to increased incidence of cancer-associated thrombosis (CAT), with the hypothesis that circulating tumor microemboli (CTM) may express more thrombosis-related proteins than CTCs. (3) Understanding the effects of aspirin or NOACs on cancer-associated thrombosis and CTM formation.",[25,26],"Tumor Cells, Circulating","Venous Thrombosis",[28,29,30,31,32],"Cancer","Thrombosis","Venous thromboembolism","Circulating tumor cells","Endovascular therapy","RECRUITING","2025-09-19",{"date":36,"type":37},"2025-09-24","ACTUAL",{"date":39,"type":37},"2024-05-28",{"date":41,"type":20},"2027-04-30",{"name":43,"class":44},"Chang Gung Memorial Hospital","OTHER",""]